Residency · Residency · Physical Medicine Rehabilitation
Ultrasound-Guided Peripheral Nerve Hydrodissection
Introduction
Peripheral nerve hydrodissection is an ultrasound-guided technique in which fluid is injected around a nerve to separate it from surrounding tissue, release adhesions, and reduce mechanical compression. This minimally invasive approach has gained traction in physiatric and interventional pain practice for treating nerve entrapment syndromes, including carpal tunnel syndrome, cubital tunnel syndrome, and other peripheral neuropathies where nerve mobility is compromised by scar tissue, fibrosis, or anatomic compression.
Mechanism of Action
Proposed Therapeutic Effects
Mechanical separation of the nerve from adjacent fascial planes and adhesions. Reduction of perineural edema and inflammatory mediators. Restoration of normal nerve gliding and excursion. Disruption of neovascularity and accompanying nociceptive nerve fibers.
Temporary decompression that may allow nerve recovery. Potential neurotrophic effects depending on injectate (e.g., dextrose, PRP).
Pathophysiology of Nerve Entrapment
Chronic compression leads to focal demyelination and axonal damage. Perineural fibrosis reduces nerve mobility and increases susceptibility to traction. Edema within the nerve (increased cross-sectional area on ultrasound). Double-crush phenomenon: proximal compression sensitizes distal sites. Hydrodissection targets the perineural space between epineurium and surrounding tissue.
Technique
General Approach
High-frequency linear ultrasound probe (12-18 MHz). Sterile technique with probe cover and sterile gel. 25-gauge or 27-gauge needle for superficial nerves; 22-gauge for deeper targets. In-plane needle approach with continuous visualization of needle tip.
Injectate volume: 1-10 mL depending on target and anatomic space. Advance needle to perineural space; inject fluid to separate nerve from adjacent tissue. Observe real-time lifting and separation of the nerve ("hydrodissection effect").
Injectates
Normal saline: Most common; purely mechanical effect; low cost. 5% dextrose in water (D5W): Proposed neurotrophic and anti-inflammatory properties; growing evidence base. Platelet-rich plasma (PRP): Regenerative approach; limited evidence. Corticosteroid: Anti-inflammatory; concern for potential neurotoxicity with direct perineural injection. Local anesthetic: Provides immediate pain relief; diagnostic value; concern about neurotoxicity with repeated use.
| Injectate | Mechanism | Advantages | Disadvantages |
|---|---|---|---|
| Normal saline | Mechanical separation | Low cost, safe | Short-duration effect |
| 5% Dextrose (D5W) | Neurotrophic, anti-inflammatory | Growing evidence, safe | Higher cost than saline |
| PRP | Regenerative | Potential tissue healing | Limited evidence, high cost |
| Corticosteroid | Anti-inflammatory | Strong anti-inflammatory effect | Potential neurotoxicity |
| Local anesthetic | Nerve blockade | Immediate pain relief, diagnostic | Neurotoxicity risk with repeated use |
Clinical Applications
Carpal Tunnel Syndrome
Most studied indication for nerve hydrodissection. Target: Median nerve at the carpal tunnel between the flexor retinaculum and flexor tendons. Pre-procedural assessment: Cross-sectional area (CSA) of median nerve; normal <10 mm2 at inlet. Technique: Ulnar-side in-plane approach; inject between nerve and flexor retinaculum.
Multiple RCTs demonstrate improvement in VAS pain scores, Boston Carpal Tunnel Questionnaire, and electrodiagnostic parameters. May serve as alternative or bridge to surgical release in mild-moderate cases.
Cubital Tunnel Syndrome
Target: Ulnar nerve at the cubital tunnel (between medial epicondyle and olecranon). Hydrodissection separates nerve from the cubital tunnel retinaculum and surrounding adhesions. Assess for ulnar nerve subluxation before and during procedure. Emerging evidence; fewer controlled trials than carpal tunnel.
Radial Nerve Entrapment
Posterior interosseous nerve at the arcade of Frohse. Superficial branch of radial nerve at the brachioradialis fascia (Wartenberg syndrome). Hydrodissection may relieve compression at fascial tunnels.
Lower Extremity Applications
Common peroneal nerve at the fibular head. Tarsal tunnel syndrome (posterior tibial nerve). Morton neuroma (interdigital nerve hydrodissection). Lateral femoral cutaneous nerve (meralgia paresthetica).
Other Targets
Suprascapular nerve at the suprascapular notch. Brachial plexus components in thoracic outlet syndrome (emerging). Post-surgical scar-related nerve entrapment at any site.
Evidence Base
Carpal Tunnel Syndrome Evidence
Multiple RCTs show hydrodissection with D5W or saline superior to no treatment. Comparable short-term outcomes to corticosteroid injection in some studies. Duration of benefit: 3-6 months; may require repeat procedures. Limited head-to-head comparison with surgical release.
Limitations of Current Evidence
Heterogeneity in injectate type, volume, and number of treatments. Many studies are single-center with small sample sizes. Lack of long-term follow-up (>12 months) in most trials. Optimal injectate, volume, and frequency of treatment not established. Need for sham-controlled trials to account for placebo effect.
Complications and Safety
Generally well-tolerated with a favorable safety profile. Nerve injury: Rare; minimized by maintaining visualization of needle tip away from nerve fascicles. Transient paresthesias during procedure (common, not a complication). Infection: Rare with aseptic technique.
Vascular injury: Identified and avoided with pre-procedural Doppler assessment. Post-procedural pain or swelling: Usually self-limited (24-48 hours).
Integration into Practice
Often combined with nerve gliding exercises and ergonomic modifications post-procedure. May delay or obviate the need for surgical decompression in select patients. Serial treatments (2-3 sessions, 4-6 weeks apart) may provide cumulative benefit. Electrodiagnostic studies before and after treatment help document functional improvement. Patient selection: best candidates have mild-moderate entrapment without severe axonal loss.
Key Clinical Pearls
- Ultrasound-guided hydrodissection is most established for carpal tunnel syndrome, where multiple RCTs demonstrate improvement in pain, function, and nerve conduction parameters. 2. The technique relies on continuous in-plane needle visualization to ensure fluid is deposited in the perineural space between the nerve and compressing structure, not into the nerve itself. 3. Five percent dextrose in water (D5W) has emerged as a preferred injectate due to proposed neurotrophic properties and favorable safety profile compared to corticosteroids. 4. Hydrodissection is best suited for mild-to-moderate nerve entrapment; patients with severe axonal loss on electrodiagnostic testing are more likely to require surgical decompression.
References
- Wu YT, et al. "Ultrasound-Guided Hydrodissection with 5% Dextrose for Carpal Tunnel Syndrome: A Randomized Controlled Trial." Ann Neurol. 2019;85(3):359-367.
- Evers S, et al. "Ultrasound-Guided Hydrodissection for Carpal Tunnel Syndrome: A Systematic Review." Hand. 2022;17(3):535-543.
- Cass SP. "Ultrasound-Guided Nerve Hydrodissection: What is it? A Review of the Literature." Curr Sports Med Rep. 2016;15(1):20-22.
- Lam KHS, et al. "Ultrasound-Guided Nerve Hydrodissection for Pain Management: Rationale, Methods, Current Literature, and Theoretical Mechanisms." J Pain Res. 2020;13:1957-1968.